Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

Aphria

Cronos Group

HEXO Corp

Tilray Brands

Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability.

Cannabis Stocks See Rising Tide in Short Interest

The biggest marijuana stock in the world by market cap has a long way to go before it becomes investment-worthy.

5 Reasons Canopy Growth Still Isn't a Buy

Can you pick a winner between the two cannabis giants?

Better Marijuana Stock to Buy: Cronos Group or Canopy Growth?

Constellation Brands

The beer maker now has a 38.6% stake in Canopy Growth.

Constellation Brands Just Upped Its Stake In Canopy Growth. Here's Why The Pot Stock Is A Buy

With Canada starting to reopen again combined with strong financial backing for Canopy Growth, CGC stock is very compelling. However, it's not going to immediately become a superstar.

Canopy Growth Is the Definition of a Long-Term Investment

Amazon

Control4

Carvana

Kinross Gold

Block

TriNet Group

Trade Desk

Voyager Therapeutics

Young investors can leverage their extra time to bet on high-growth stocks that are likely to jump on developing trends.
The post 10 Best High-Growth Stocks to Buy for Young Investors appeared first on InvestorPlace.

10 Best High-Growth Stocks to Buy for Young Investors

The marijuana stock rebound in 2020 has run into a brick wall, but the fundamentals supporting the industry continue to improve.
The post 4 Marijuana Stocks to Buy for the Big 2020 Rebound (Once Coronavirus Fears Fade) appeared first on InvestorPlace.

4 Marijuana Stocks to Buy for the Big 2020 Rebound (Once Coronavirus Fears Fade)

Which stock wins in a battle between the top Canadian cannabis producer and one of the leading U.S. cannabis operators?

Better Marijuana Stock: Canopy Growth vs. Cresco Labs

Canopy's biggest shareholder is now an even bigger shareholder.

3 Reasons Constellation Brands Just Upped Its Stake in Canopy Growth

Find out who's pulling the trigger on cannabis.

Stock Market Wrap-Up: Buffett Talks Pot, but Here's Who's Buying Marijuana Stock

Blue Apron

Beyond Meat

Chegg

EverBank Financial

Match Group

Plug Power

Revolve

Stitch Fix

Snap

Tabula Rasa Healthcare

Tesla

Wayfair

For investors looking for home run hits, these 15 heavily shorted stocks with huge short squeeze potential are worth a look.

15 Tightly Wound Stocks With ‘Pop’ Potential

Another show of confidence from Constellation Brands and improving chances for a major pattern bottom point towards the possibility of a double in Canopy shares by years end
The post Why Canopy Growth Is Worth a Second Look Today appeared first on InvestorPlace.
More From InvestorPlace
		
					
				
					America’s #1 Stock Picker Reveals Next 1,000% Winner				
			
					
				
					25 Stocks You Should Sell Immediately				
			
					
				
					#1 Under-the-Radar 5G Stock to Buy Now				
			
					
				
					The 1 Stock All Retirees Must Own

Why Canopy Growth Is Worth a Second Look Today

Who wins in a matchup between these two cannabis giants?

Better Buy: Canopy Growth vs. Aphria

Curaleaf Holdings, Inc.

Charlotte's Web Holdings, Inc.

Coca-Cola

Starbucks

Trulieve Cannabis Corp.

It's not going to turn bad stocks into good investments.

Why Marijuana Legalization Won't Solve the Industry's Problems

Constellation Brands Inc. STZ, -1.89% said late Friday that it had increased its stake in Canopy Growth Corp.

Corona beer maker Constellation increases stake in marijuana producer Canopy Growth, shares rise 10%

Not for the first time in the recent past, the company is trimming its workforce.

Canopy Growth Laying Off 200 Workers

The cannabis giant announces another round of layoffs as the company moves to cut costs.

Layoffs Continue At Canopy Growth, Constellation Brands’ Struggling Cannabis Producer

Canadian pot producer Canopy Growth Corp  said on Wednesday it would lay off 200 employees in North America and the UK, according to an internal announcement seen by Reuters.

Canopy Growth Corp to lay off 200 employees

Marijuana producer Canopy Growth Corp. CGC, +1.79% WEED, +1.45% said Wednesday that it had laid off 200 people across Canada, the United Kingdom and the U.S.

Cannabis producer Canopy Growth lays off 200 amid restructuring

Both of these stocks are down more than 60% in the past year, but which one is more likely to bounce back?

Better Buy: OrganiGram Holdings vs. Canopy Growth

Both cannabis companies have big-name partners. But one has a lot more of what's most important right now.

Better Marijuana Stock: Canopy Growth vs. Tilray

At one point pot stocks were all the rage. CGC stock is trying to make a comeback in spite of the drubbing it took during the Covid-19 crash.

Canopy Growth Stock has Upside Potential Emerging From This Covid-19 Hole

GW Pharmaceuticals

Cannabis short sellers got off to a hot start in 2020 after netting nearly $1 billion in profits in 2019.

Cannabis Stock Rally Puts Short Sellers In The Red For 2020

Investors are punishing CGC stock for cost-cutting measures, but Canopy Growth now is more likely to survive Covid-19 than its bigger peers. 
The post Slimmed-Down Canopy Growth Stock Is a Cannabis Winner appeared first on InvestorPlace.

Slimmed-Down Canopy Growth Stock Is a Cannabis Winner

Big cannabis stocks are rallying on Monday, with many posting double-digits gains.

Why Tilray, Curaleaf, Canopy Growth And Other Cannabis Stocks Are Rallying Today

News for Canopy Growth Stock (CGC)